Aspiriant LLC’s Vanguard Morningstar Total Stock Market ETF VTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.3M Buy
103,363
+9,036
+10% +$3.23M 0.94% 16
2026
Q1
$30.3M Sell
94,327
-65
-0.1% -$21.8K 0.86% 21
2025
Q4
$31.6M Sell
94,392
-1,214
-1% -$404K 0.91% 19
2025
Q3
$31.4M Sell
95,606
-240
-0.3% -$75.8K 0.96% 18
2025
Q2
$29.1M Buy
95,846
+3,579
+4% +$1.01M 0.93% 19
2025
Q1
$25.4M Buy
92,267
+1,179
+1% +$343K 0.88% 17
2024
Q4
$26.4M Sell
91,088
-455
-0.5% -$133K 0.95% 16
2024
Q3
$25.9M Sell
91,543
-765
-0.8% -$209K 0.98% 17
2024
Q2
$24.7M Sell
92,308
-195
-0.2% -$50.5K 1.01% 17
2024
Q1
$24M Buy
92,503
+76
+0.1% +$18.8K 1% 16
2023
Q4
$21.9M Buy
92,427
+49,817
+117% +$11M 0.99% 20
2023
Q3
$9.05M Buy
42,610
+3,282
+8% +$726K 0.46% 33
2023
Q2
$8.66M Sell
39,328
-1,065
-3% -$222K 0.44% 35
2023
Q1
$8.24M Sell
40,393
-2,458
-6% -$492K 0.43% 36
2022
Q4
$8.19M Buy
42,851
+2,191
+5% +$422K 0.42% 34
2022
Q3
$7.3M Buy
40,660
+622
+2% +$124K 0.36% 35
2022
Q2
$7.55M Buy
40,038
+805
+2% +$165K 0.36% 35
2022
Q1
$8.93M Buy
39,233
+54
+0.1% +$12.1K 0.49% 29
2021
Q4
$9.46M Sell
39,179
-4,235
-10% -$1,000K 0.51% 26
2021
Q3
$9.64M Sell
43,414
-272
-0.6% -$62K 0.57% 25
2021
Q2
$9.73M Buy
43,686
+587
+1% +$127K 0.55% 25
2021
Q1
$8.91M Sell
43,099
-891
-2% -$180K 0.57% 25
2020
Q4
$8.56M Sell
43,990
-551
-1% -$101K 0.58% 24
2020
Q3
$7.58M Sell
44,541
-1,478
-3% -$249K 0.59% 27
2020
Q2
$7.21M Buy
46,019
+4,734
+11% +$698K 0.67% 26
2020
Q1
$5.32M Sell
41,285
-18,541
-31% -$2.87M 0.52% 28
2019
Q4
$9.79M Sell
59,826
-2,978
-5% -$467K 0.91% 23
2019
Q3
$9.48M Sell
62,804
-4,423
-7% -$667K 0.85% 24
2019
Q2
$10.1M Buy
67,227
+8,813
+15% +$1.3M 0.84% 26
2019
Q1
$8.45M Buy
58,414
+10,629
+22% +$1.48M 0.69% 31
2018
Q4
$6.1M Buy
47,785
+8,358
+21% +$1.15M 0.46% 38
2018
Q3
$5.9M Sell
39,427
-30
-0.1% -$4.42K 0.5% 40
2018
Q2
$5.54M Buy
39,457
+875
+2% +$122K 0.47% 43
2018
Q1
$5.24M Buy
38,582
+32,551
+540% +$4.56M 0.46% 44
2017
Q4
$828K Sell
6,031
-17,574
-74% -$2.35M 0.24% 39
2017
Q3
$3.06M Buy
23,605
+6,593
+39% +$835K 0.26% 56
2017
Q2
$2.12M Sell
17,012
-1,385
-8% -$171K 0.18% 76
2017
Q1
$2.23M Buy
18,397
+1,289
+8% +$154K 0.19% 78
2016
Q4
$1.97M Sell
17,108
-36
-0.2% -$4.05K 0.18% 74
2016
Q3
$1.91M Buy
17,144
+191
+1% +$21.2K 0.19% 73
2016
Q2
$1.82M Sell
16,953
-2,214
-12% -$235K 0.17% 82
2016
Q1
$2.01M Buy
19,167
+8,658
+82% +$858K 0.19% 70
2015
Q4
$1.1M Sell
10,509
-20,358
-66% -$2.14M 0.12% 43
2015
Q3
$3.22M Buy
30,867
+10,509
+52% +$1.1M 0.27% 29
2015
Q2
$2.18M Buy
20,358
+10,189
+100% +$1.11M 0.21% 26
2015
Q1
$1.09M Hold
10,169
0.14% 38
2014
Q4
$1.08M Buy
10,169
+1,238
+14% +$128K 0.14% 35
2014
Q3
$904K Buy
8,931
+11
+0.1% +$1.13K 0.13% 35
2014
Q2
$908K Sell
8,920
-2,858
-24% -$282K 0.13% 48
2014
Q1
$1.15M Sell
11,778
-708
-6% -$67.8K 0.17% 41
2013
Q4
$1.2M Buy
12,486
+7,598
+155% +$699K 0.19% 35
2013
Q3
$428K Sell
4,888
-2,916
-37% -$253K 0.08% 35
2013
Q2
$645K Buy
+7,804
New +$647K 0.1% 41

Other funds holding VTI

Aspiriant LLC's VTI Position: Q2 2026 in Review

Aspiriant LLC increased its Vanguard Morningstar Total Stock Market ETF (VTI) stake by 9.6% in Q2 2026, buying an estimated $3.23M and bringing the position to 103,363 shares worth $38.3M. The position accounts for 0.94% of the portfolio, ranked #16.

Aspiriant LLC first reported a position in VTI in Q2 2013 and has held it in 53 quarters since. 3,681 funds tracked by Wall St. Rank hold VTI as of Q2 2026.

  • Aspiriant LLC held 103,363 shares of Vanguard Morningstar Total Stock Market ETF worth $38.3M as of Q2 2026.
  • Aspiriant LLC bought 9,036 Vanguard Morningstar Total Stock Market ETF shares in Q2 2026, an estimated $3.23M.
  • Vanguard Morningstar Total Stock Market ETF made up 0.94% of Aspiriant LLC's portfolio in Q2 2026, its #16 holding.
  • Aspiriant LLC first reported a position in Vanguard Morningstar Total Stock Market ETF in Q2 2013 and has held it in 53 quarters since.
  • 3,681 funds tracked by Wall St. Rank held Vanguard Morningstar Total Stock Market ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.